Empagliflozin vs Sitagliptin
Empagliflozin vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Empagliflozin and Sitagliptin.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Sitagliptin β 12.4 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Sitagliptin β C16H15F6N5O.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Sitagliptin β 407.3140 g/mol.
Type: Empagliflozin β Small molecule; Sitagliptin β Small molecule.